Compound Radar

Astrana Health, Inc. (ASTH) Stock Analysis

Price $38.10
Market cap $1.89B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

60
60/100 Good Quality
  • Financial Health 40
  • Profitability 75
  • Business Quality 60
  • Balance Sheet 40
  • Cash Flow 80

Why this rating?

Health 60/100 — Good Quality

Strongest Cash Flow 80/100
Softest Balance Sheet 40/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Astrana Health, Inc. (ASTH) is a Medical Care Facilities company in the Healthcare sector. Compound Radar rates Astrana Health, Inc. 60/100 (Good Quality) due to solid business quality, strong revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Strong
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 46.46
  • Forward P/E 10.76
  • EV/Revenue 0.6

Profitability

  • Revenue Growth 48.5%
  • Gross Margin 10.5%
  • Operating Margin 3.5%
  • Net Margin 1.1%
  • ROE 6.9%

Financial strength

  • Cash $400.79M
  • Debt $979.41M
  • Net Cash $-578.62M
  • Free Cash Flow $104.49M
  • Current Ratio 1.23

Similar companies

Peers in Medical Care Facilities, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Care Facilities →

FAQ

How Compound Radar scores and tracks Astrana Health, Inc. (ASTH).

View Methodology & FAQ →